Biocartis
Develops diagnostic systems to reduce the cost and improve the efficacy of personalised medical treatments
Biocartis has raised €323M across 9 funding rounds from 3 investors, most recently a round in Apr 2017. Based in Lausanne, Switzerland; founded 2007; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€323M
€323,468,415
Funding rounds
9
Investors
3
distinct backers
Active since
2009-10
latest 2017-04
Funding by year
EUR raised per yearBiocartis — funding by year — interactive chart.
Data table
| Biocartis — funding by year | |
|---|---|
| 2009 | €10M |
| 2010 | €30M |
| 2011 | €71M |
| 2012 | €35M |
| 2013 | €32M |
| 2014 | €66M |
| 2017 | €80M |
Signals
Medium confidenceRaise-next likelihood7
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood15
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 9 rounds raised
- ▼ Old (19y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
9 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-04-01 | Other | €80M | — | View deal → |
| 2014-09-01 | Series D+ | €65M | — | View deal → |
| 2014-06-01 | Grant | €1.7M | — | View deal → |
| 2013-11-01 | Series D+ | €30M | — | View deal → |
| 2013-06-01 | Grant | €1.8M | — | View deal → |
| 2012-12-01 | Series D+ | €35M | — | View deal → |
| 2011-11-01 | Series C | €71M | — | View deal → |
| 2010-04-01 | Series B | €30M | Advent Venture Partners,Aescap,Offshore Investment | View deal → |
| 2009-10-01 | Series A | €10M | Advent Venture Partners,Aescap | View deal → |
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData